Healio: Antivirals reduce long COVID incidence at 90 days in patients with rheumatic diseases We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Understanding the Context

Antiviral therapy reduced incidence of long COVID-19 ... Antivirals reduce long COVID incidence at 90 days in patients with rheumatic diseases Ars Technica: COVID antiviral Paxlovid to see price increase following 400% vaccine hike kjrh.com: Pfizer begins next phases of trial of antiviral COVID-19 pill for children Pfizer announced Wednesday it has begun phases 2 and 3 of its pediatric clinical trial for Paxlovid, its COVID-19 antiviral treatment. The study will look into how effective and safe the treatment is ... Pfizer begins next phases of trial of antiviral COVID-19 pill for children The Conversation: Getting antivirals for COVID too often depends on where you live and how wealthy you are Medical experts recommend antivirals for people aged 70 and older who get COVID, and for other groups at risk of severe illness and hospitalisation from COVID.

Key Insights

But many older Australians have missed ... Getting antivirals for COVID too often depends on where you live and how wealthy you are FILE - The anti-viral drug Paxlovid is displayed in New York, Aug. 1, 2022. For some people with COVID-19, antiviral pills that can be taken at home can lessen the chances of winding up in the ... Medical Xpress: COVID wave: What's the latest on antiviral drugs, and who is eligible in Australia?

Final Thoughts

Australia is experiencing a fresh wave of COVID, seeing increasing cases, more hospitalizations and a greater number of prescriptions for COVID antivirals dispensed over recent months. In the early ... COVID wave: What's the latest on antiviral drugs, and who is eligible in Australia? MedPage Today: Flu Antiviral Use Among Hospitalized Kids Fell During COVID Pandemic